A Rare Case Report of Neurological Condition: Moersch-Woltman Syndrome with Positive Anti-GAD Antibodies

Authors

  • Aakanksha Pitliya MBBS, Extern, Neurology Services Inc, Alexandria, Virginia, USA.

Keywords:

Stiff-Person Syndrome, Dyskinesias/etiology, Movement disorders, Muscle Cramp/physiopathology, Moersch-Woltman Syndrome, Antibodies to glutamic acid decarboxylase (anti-GAD), Glutamic acid decarboxylase, Glutamic acid decarboxylase antibodies, Autoimmune Diseases, Neurology, Neurological Examination, Hereditary Hyperekplexia, Autoimmune Diseases of the Nervous System, Spinal Cord Diseases, Neuromuscular Diseases, Nervous System Diseases

Abstract

Background: Moersch-Woltman Syndrome (MWS), also known as Stiff person syndrome (SPS), is a rare, progressive condition of the central nervous system. Symptoms can include severe immobility, rigidity, and painful muscle spasms in the trunk and limbs. Muscle spasms can occur in MWS patients because they are more sensitive to noise, rapid movements, and mental disturbance. The condition affects women twice as frequently as it does males. It is a rare disease, affecting only 1-2 people per million. The case report aims to highlight the importance of the diagnostic challenges associated with MWS and the significance of glutamic acid decarboxylase (GAD) antibodies.

The case: A 57-year-old female patient presents with history of migraine headaches, anxiety, and depression. The patient experienced widespread and distressing muscle spasms affecting the shoulders, upper and lower back, and limited range of motion in the neck. Physical examination revealed dense diffuse muscle stiffness throughout the body. Further investigations were ordered, including a comprehensive range of laboratory tests and imaging tests. A positive test for GAD antibodies confirmed the diagnosis of MWS. Treatment included administration of Clonazepam and Baclofen. A follow-up appointment, three weeks later, indicated a noticeable 15-20% reduction in spasticity.

Conclusion: This case highlights the crucial role of anti-GAD antibodies in confirming the diagnosis of SPS. Healthcare professionals should consider testing for these antibodies in patients presenting with the described symptoms. A multidisciplinary approach involving neurologists, physical therapists, psychiatrists, and orthopedic surgeons is essential to provide comprehensive care and optimizing outcomes for individuals with MWS.

Metrics

Metrics Loading ...

References

McEvoy KM. Stiff-man syndrome. Mayo Clin Proc. 1991;66(3):300-4.

Hicken J, Ramirez D, Rigby M, Minasian A. Stiff-Person Syndrome: Seeing Past Comorbidities to Reach the Correct Diagnosis. Case Rep Neurol Med. 2021;2021:6698046.

Rakocevic G, Floeter MK. Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes. Muscle Nerve. 2012;45(5):623–34.

Nasri A, Gharbi A, Ouali U, Mrabet S, Souissi A, Jomli R, et al. Psychiatric Symptoms in Stiff-Person Syndrome: A Systematic Review and a Report of Two Cases. J Acad Consult Liaison Psychiatry. 2022;(2):S2667-2960.

Alexopoulos H, Dalakas MC. A critical update on the immunopathogenesis of Stiff Person Syndrome. Eur J Clin Invest. 2010;40(11):1018–25.

Ortiz JF, Ghani MR, Morillo Cox Á, Tambo W, Bashir F, Wirth M. et al. Stiff-Person Syndrome: A Treatment Update and New Directions. Cureus. 2020;12(12):e11995.

Dalakas MC. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr Treat Options Neurol. 2009;11(2):102-10.

Ciccotto G, Blaya M, Kelley RE. Stiff person syndrome. Neurol Clin. 2013;31(1):319-28.

Hadavi S, Noyce AJ, Leslie RD, Giovannoni G. Stiff person syndrome. Pract Neurology. 2011;11(5):272-82.

Ogilvie RJ, Kolski HK. Adolescent Stiff Person Syndrome: Long-Term Symptom Remission on Immunomodulatory Therapy. Can J Neurol Sci. 2019;46(5):631-2.

Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary Lateral Sclerosis: Clinical Features, Neuropathology and Diagnostic Criteria. Brain. 1992;115(2):495–520 .

Dalakas MC. Therapies in Stiff-Person Syndrome Advances and Future Prospects Based on Disease Pathophysiology. Neurol Neuroimmunol Neuroinflamm. 2023;10(3):e200109.

Saigal R, Goyal L, Yadav RN, Agrawal A, Mital P, Patel B. Stiff Person Syndrome. J Assoc Physicians India. 2015;63:0004-5772.

Galli JR, Austin SD, Greenlee JE, and Clardy SL. Stiff person syndrome with anti-GAD65 antibodies within the national veterans affairs health administration. Muscle Nerve. 2018;58(6):801–4.

Downloads

Published

2023-09-15

How to Cite

Pitliya, A. (2023). A Rare Case Report of Neurological Condition: Moersch-Woltman Syndrome with Positive Anti-GAD Antibodies. International Journal of Medical Students, 11(3), 233–236. Retrieved from https://ijms.pitt.edu/IJMS/article/view/2053

Issue

Vol. 11 No. 3 (2023)

Section

Case Report

Categories

License

Copyright (c) 2023 Aakanksha Pitliya

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org